Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior

被引:73
|
作者
Fox, James H. [1 ]
Lowry, Christopher A.
机构
[1] Univ Colorado, Dept Integrat Physiol, Behav Neuroendocrinol Lab, 1725 Pleasant St, Boulder, CO 80309 USA
基金
美国国家科学基金会;
关键词
anxiety; corticotropin-releasing factor; dorsal raphe nucleus; emotional behavior; serotonin; DORSAL RAPHE NUCLEUS; MESSENGER-RNA EXPRESSION; EDINGER-WESTPHAL NUCLEUS; MEDIAL PREFRONTAL CORTEX; IMPAIRED STRESS-RESPONSE; C-FOS EXPRESSION; TOPOGRAPHICALLY ORGANIZED SUBPOPULATIONS; INDUCED REPRODUCTIVE DYSFUNCTION; CENTRAL-NERVOUS-SYSTEM; ANXIETY-LIKE BEHAVIOR;
D O I
10.3389/fnins.2013.00169
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Corticotropin-releasing factor (CRF) is a 41-amino acid neuropeptide that is involved in stress-related physiology and behavior, including control of the hypothalamic-pituitary-adrenal (HPA) axis. Members of the CRF family of neuropeptides, including urocortin 1 (UCN 1), UCN 2, and UCN 3, bind to the G protein-coupled receptors, CRF type 1 (CRF1) and CRF2 receptors. In addition, CRF binding protein (CRFBP) binds both CRF and UCN 1 and can modulate their activities. There are multiple mechanisms through which CRF-related peptides may influence emotional behavior, one of which is through altering the activity of brainstem neuromodulatory systems, including serotonergic systems. CRF and CRF-related peptides act within the dorsal raphe nucleus (DR), the major source for serotonin (5-HT) in the brain, to alter the neuronal activity of specific subsets of serotonergic neurons and to influence stress-related behavior. CRF-containing axonal fibers innervate the DR in a topographically organized manner, which may contribute to the ability of CRF to alter the activity of specific subsets of serotonergic neurons. CRF and CRF-related peptides can either increase or decrease serotonergic neuronal firing rates and serotonin release, depending on their concentrations and on the specific CRF receptor subtype(s) involved. This review aims to describe the interactions between CRF-related peptides and serotonergic systems, the consequences for stress-related behavior, and implications for vulnerability to anxiety and affective disorders.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] CORTICOTROPIN-RELEASING FACTOR
    DUNTAS, L
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (19) : 794 - 794
  • [22] Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor
    Kagamiishi, Y
    Yamamoto, T
    Watanabe, S
    BRAIN RESEARCH, 2003, 991 (1-2) : 212 - 221
  • [23] HUMAN PLACENTAL CORTICOTROPIN-RELEASING FACTOR IS IDENTICAL TO HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR
    STALLA, GK
    BOST, H
    KALIEBE, T
    HUBER, M
    STALLA, J
    PFEIFFER, D
    VONWERDER, K
    MULLER, OA
    ACTA ENDOCRINOLOGICA, 1986, 111 : 169 - 169
  • [24] Functional Significance of the signal Peptides of Corticotropin-Releasing Factor Receptors
    Schuelein, Ralf
    Gibert, Arthur
    Rutz, Claudia
    CURRENT MOLECULAR PHARMACOLOGY, 2017, 10 (04) : 311 - 317
  • [25] Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats
    Turnbull, AV
    Vale, W
    Rivier, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 303 (03) : 213 - 216
  • [26] CORTICOTROPIN-RELEASING FACTOR EFFECTS ON BEHAVIOR DURING ISOLATION
    HENNESSY, MB
    LONG, SJ
    NIGH, CK
    DEVELOPMENTAL PSYCHOBIOLOGY, 1995, 28 (03) : 187 - 187
  • [27] Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides
    Mazur, AW
    Wang, F
    Tcheiner, M
    Donnelly, E
    Isfort, RJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (13) : 3450 - 3454
  • [28] SAFETY OF CORTICOTROPIN-RELEASING FACTOR
    SCHULTE, HM
    CHROUSOS, GP
    CHATTERJI, DC
    GOLD, PW
    OLDFIELD, EH
    LORIAUX, DL
    LANCET, 1983, 1 (8335): : 1222 - 1222
  • [29] CORTICOTROPIN-RELEASING FACTOR - INTRODUCTION
    VALE, W
    CIBA FOUNDATION SYMPOSIA, 1993, 172 : 1 - 4
  • [30] SAFETY OF CORTICOTROPIN-RELEASING FACTOR
    HERMUS, A
    RAEMAEKERS, JMM
    PETERS, GFFM
    BARTELINK, AKM
    SMALS, AGH
    KLOPPENBORG, PWC
    LANCET, 1983, 2 (8341): : 112 - 112